Cargando…
A single dose of in situ gel formulation of antimalarial drug chloroquine phosphate as a sustained prophylactic candidate for COVID-19
In the ongoing COVID-19 outbreak, a prophylactic drug is strongly needed to stop the spread of this disease. Chloroquine (CQ) has been proposed as a prophylactic for individuals who are likely to be exposed to the virus. This study aimed to study the ability of CQ to act as a prophylactic treatment...
Autor principal: | Zelai, Noha Talal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832181/ https://www.ncbi.nlm.nih.gov/pubmed/33532356 http://dx.doi.org/10.4103/japtr.JAPTR_89_20 |
Ejemplares similares
-
Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
por: Aguiar, Anna C.C., et al.
Publicado: (2018) -
Randomized Dose-Ranging Controlled Trial of AQ-13, a Candidate Antimalarial, and Chloroquine in Healthy Volunteers
por: Mzayek, Fawaz, et al.
Publicado: (2007) -
A Novel In Situ Gel Formulation of Ranitidine for Oral Sustained Delivery
por: Xu, Haoping, et al.
Publicado: (2014) -
Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
por: Farrell, Donald F
Publicado: (2012) -
Building on Surface-Active Ionic Liquids for the Rescuing of the Antimalarial Drug Chloroquine
por: Silva, Ana Teresa, et al.
Publicado: (2020)